Company Quick10K Filing
Novo Integrated Sciences
10-Q 2020-02-29 Filed 2020-04-20
10-Q 2019-11-30 Filed 2020-01-13
10-K 2019-08-31 Filed 2019-11-20
10-Q 2019-05-31 Filed 2019-07-11
10-Q 2019-02-28 Filed 2019-04-11
10-Q 2018-11-30 Filed 2019-01-11
10-K 2018-08-31 Filed 2018-11-06
10-Q 2018-05-31 Filed 2018-07-11
10-Q 2018-02-28 Filed 2018-04-12
10-Q 2017-11-30 Filed 2018-01-12
10-K 2017-08-31 Filed 2017-12-08
10-Q 2017-05-31 Filed 2017-07-24
10-Q 2017-03-31 Filed 2017-04-14
10-K 2016-12-31 Filed 2017-03-07
10-Q 2016-09-30 Filed 2016-10-31
10-Q 2016-06-30 Filed 2016-07-22
10-Q 2016-03-31 Filed 2016-04-29
10-K 2015-12-31 Filed 2016-03-25
10-Q 2015-09-30 Filed 2015-10-30
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-19
10-K 2013-12-31 Filed 2014-04-16
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-16
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-15
10-Q 2012-09-30 Filed 2012-11-23
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-06
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-04-14
8-K 2020-04-07
8-K 2020-03-20
8-K 2020-03-09
8-K 2020-02-04
8-K 2019-12-17
8-K 2019-10-23
8-K 2019-09-24
8-K 2019-09-11
8-K 2019-03-06
8-K 2019-02-26
8-K 2019-02-20
8-K 2019-01-31
8-K 2019-01-14
8-K 2018-12-18
8-K 2018-11-30
8-K 2018-11-23
8-K 2018-11-14
8-K 2018-10-23
8-K 2018-10-17
8-K 2018-10-10
8-K 2018-07-27
8-K 2018-05-31
8-K 2018-04-08
8-K 2018-03-19
8-K 2018-03-15
8-K 2018-01-30
8-K 2018-01-16
8-K 2017-12-29
8-K 2017-12-26

Novo Integrated Sciences Financials

NVOS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Castle Biosciences (CSTL) 334,822 85% 35.2 4% 113,200 30,864 25,513 21,812 4,580 7,539 265,251
New York & Company (NWY) 330,180 29% -12.5 -4% 486,431 430,014 850,241 249,177 -21,388 -21,254 264,615
Invesco DB US Dollar Index Bullish Fund (UUP) 329,522 16.0 6% 330,667 203 0 0 20,586 20,596 329,522
Zynex (ZYXI) 324,063 62% 25.1 37% 24,724 8,332 40,647 25,317 9,167 12,416 312,129
Atreca (BCEL) 310,800 -4.3 -16% 212,718 7,723 0 0 -33,792 -33,362 143,374
Corium (CORI) 305,900 0% -4.9 -50% 112,131 87,239 37,693 0 -56,540 -45,465 223,763
Exantas Capital (RSO) 303,730 0% 17.4 2% 2,472,193 1,912,167 46,751 0 39,535 123,013 2,145,860
Energy XXI Gulf Coast (EGC) 300,174 0% -1.3 -30% 1,032,246 929,173 454,101 0 -313,739 -174,942 228,492
South Plains Financial (SPFI) 298,399 1.1 1% 2,795,582 2,496,555 0 0 19,111 49,907 53,754
Focus Universal (FCUV) 294,910 24% -109.6 -32% 8,252 466 995 243 -2,668 -2,665 292,150
Novo Integrated Sciences (NVOS) 234,765 50% -426.2 -2% 31,682 6,368 7,002 3,529 -628 -545 232,287
Parker Drilling (PKD) 283,593 10% -10.7 -19% 667,657 312,841 602,659 60,498 -124,691 -33,643 359,519
Stereotaxis (STXS) 282,894 80% -72.5 -8% 43,306 14,588 22,010 17,619 -3,507 -3,466 251,244
Axovant Sciences (AXON) 276,117 -1.5 -165% 102,188 82,309 0 0 -168,944 -157,405 240,391
Invesco DB Oil Fund (DBO) 267,596 6.9 15% 258,073 7,694 0 0 38,599 38,637 267,596
Kush Bottles (KSHB) 386 18% -0.2 -22% 160,659 57,122 101,982 18,474 -34,905 -31,261 6,651
Invesco CurrencyShares Euro Trust (FXE) 254,678 -1.7 -1% 253,883 158 0 0 -1,435 -469 795
United Health Products (UEEC) 252,522 60% -58.8 -1,768% 234 526 25 15 -4,136 -4,292 252,434
Satsuma Pharmaceuticals (STSA) 252,234 -17.0 -6% 127,544 9,423 0 0 -8,260 -8,139 138,334
CV Sciences (CVSI) 250,868 70% -25.4 -18% 56,538 23,295 44,368 30,938 -9,924 -9,315 236,630

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash79121124625013120629891434171354151,6741,8971,2961,0378646769292,3742,478
Accounts Receivable8551,1291,2891,3491,3121,3381,4051,3791,383
Inventory
PP&E52517619701615147012109376001520571559609641729790800806
Assets17816426226275354922379358295201133232922222847312770375,3895,5144,9585,0724,8404,7435,06229,08131,682
Accounts Payable13411911675124118120163160146134161778310156121327932051,8951,7031,5751,7441,3101,3081,3681,2541,284
Long-Term Debt64968781377344611719224427230800004064284084114060000
Liabilities2,0582,2442,3542,0557978329749571,2631,3061,2211,34571464810156121327932059,9389,8039,3394,7194,5564,5704,5454,2526,368
Stockholders' Equity-1,879-2,080-2,328-1,829-522-797-925-935-884-948-925-1,145-580-626-73-3410152022245032-4,531-4,268-4,35837931020155124,86625,351
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue2,0902,2202,2542,3102,3232,3122,2002,490
Cost of Revenue1,3771,2551,4081,3381,4181,3381,4281,3211,557
Gross Profit713966846971905834884880933
R&D87043000000000000250000
SG&A9749281,0182,0101,0829271,099958996
Tax000000000
Net Income-485-501-417-409-199-165-243-283-169-192-146-327-209-328-2,360-362-13-35-68-17-37-42-37-357-616-357-1,375-218-158-251-120-99
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating-35-145-45-49-90-70-40-42-32-31-40-26-85-50-15-21-46-20-23-54-298-724-352-421-94-163-297-71
Cash Investing0-19800000000-100000-392-750-24-83-94-74-227-404
Cash Financing373422868657143512037383385502040301565152,1603,023-184-286114971,940639